Roman Schniepp Selected Research

Roman Schniepp Research Topics

4	Cerebellar Ataxia (Dysmetria) 02/2016 - 09/2011
2	Vertigo (Positional Vertigo) 02/2020 - 04/2015
2	Type 2 Episodic Ataxia 02/2016 - 04/2013
2	Gait Ataxia 02/2016 - 11/2012
2	Ataxia (Dyssynergia) 02/2016 - 01/2016
1	Stroke (Strokes) 02/2024
1	Dizziness (Lightheadedness) 02/2020
1	Hemorrhage 09/2018
1	Venous Thromboembolism 09/2018
1	Aneurysm (Aneurysms) 09/2018
1	Thrombocytopenia (Thrombopenia) 09/2018
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 09/2018
1	Nervous System Diseases (Neurological Disorders) 02/2017
1	Sarcopenia 06/2015
1	Acrophobia 04/2015
1	Bilateral Vestibulopathy 04/2015
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 04/2015
1	Cerebellar Diseases (Cerebellar Syndrome) 04/2013
1	Multiple Sclerosis 04/2013
1	Tremor (Tremors) 04/2013
1	Peptic Ulcer (Peptic Ulcers) 01/2007
1	Ganglion Cysts (Ganglion) 04/2005

5	4-Aminopyridine (4 Aminopyridine)FDA Link 02/2017 - 09/2011
2	AminopyridinesIBA 02/2017 - 02/2016
2	Potassium Channel Blockers (Blockers, Potassium Channel)IBA 02/2017 - 04/2013
2	Amino Acids FDA Link 02/2016 - 01/2016
2	acetylleucineIBA 02/2016 - 01/2016
1	1- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)IBA 02/2024
1	Heparin (Liquaemin)FDA LinkGeneric 09/2018
1	AmifampridineIBA 02/2017
1	Chlorzoxazone FDA LinkGeneric 02/2016
1	Acetazolamide (Diamox)FDA LinkGeneric 02/2016
1	Hypnotics and Sedatives (Sedatives)IBA 06/2015
1	Antihypertensive Agents (Antihypertensives)IBA 06/2015
1	N 30IBA 04/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2007
1	Retinaldehyde (Retinal)IBA 04/2005
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2005
1	GlucocorticoidsIBA 04/2005
1	Phosphotransferases (Kinase)IBA 04/2005

1	Thrombectomy 02/2024
1	Occupational Therapy (Therapy, Occupational) 02/2020
1	Combined Modality Therapy 02/2020
1	Drug Therapy (Chemotherapy) 02/2016
1	Therapeutics 04/2015
1	Activities of Daily Living (ADL) 04/2013